Clinical trial
Paclitaxel Plus Chemoprotection With Amifostine in Treating Patients With…
NCT00003555 · State University of New York - Upstate Medical University, Other · Completed
Key facts
| NCT number | NCT00003555 |
|---|---|
| Title | Paclitaxel Plus Chemoprotection With Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors |
| Official title | Use of Weekly One Hour Paclitaxel Infusion With Dose Escalation for Recurrent and Resistant Cancers, Using Amifostine as a Cytoprotector |
| Lead sponsor | State University of New York - Upstate Medical University, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | amifostine trihydrate, paclitaxel |
| Enrollment | 20 |
| Start date | Jul 1, 1998 |
| Completion | May 1, 2003 |
| First posted | Aug 16, 2004 |
| Last update posted | Jun 26, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: